New Pilot Could Reshape Controversial Drug Discount Program (Law.com)
Heath Ingram, a partner at Goodwin based in New York who represents both drug manufacturers and healthcare providers covered by the 340B program, hailed the new pilot as a major step toward addressing these concerns. “In my opinion, the pilot program is one of the most essential reforms the 340B program needs in order to ensure sustainability of the program and to help build trust between manufacturers and covered entities as well as the [pharmacy benefit managers] and third-party administrators who operate in between them,” he said in a phone interview.
Read the Law.com article for more.